This is in line with several studies that FGFR inhibitors interfere the fibrosis process induced by TGF‐β1,29 non‐specific inhibition of FGFR can reduce BLM‐induced IPF in rodents30 and specific FGFR1 inhibitors (NP603) can reduce rat liver fibrosis caused by tetrachlorocarbon.31 This evidence concerns the gene TGFB1 and Hepatic fibrosis.